Pharmaceuticals, Biotechnology and Life Sciences
Exscientia has made a deal to acquire GT Apeiron’s share of its oral CDK7 inhibitor programme, gaining full control of GTAEXS617 (‘617) and all related intellectual property, it said Thursday....
ProKidney Corp., a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease, today announced the pricing of an underwritten public offering and a concurrent registered direct offering of...
World Food Safety Day is jointly facilitated by the Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization (WHO), and aims to draw attention and inspire action to help prevent, detect and manage foodborne risks,...
The society is changing rapidly, millennials are now 40 years old people, and it's OK. The Gen-X folks are already...
Because we've seen a lot of antivax narratives, let's just give you a brief history of immunization. A Journey Through...
LA JOLLA, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
DOYLESTOWN, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage…
Late-breaking data at WCLC show Libtayo monotherapy nearly doubled median overall survival and reduced the risks of death and disease…
If approved, neffy 1 mg will be the first and only needle-free epinephrine treatment available for younger school-aged children The…
CAMBRIDGE, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the…
LONDON, Sept. 09, 2024 (GLOBE NEWSWIRE) — Treos Bio announced the results of a meta-analysis from three clinical trials evaluating…
September 18th Event in New York City to Include a Review of the Opportunity for Investigational Therapy IMNN-001 (IL-12) to…
— Recorded First Quarter Revenue of $40.2 Million — — Signed $66 Million in Net New Business, Resulting in Backlog…
DOYLESTOWN, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage…
SUNNYVALE, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics…
